Identification of proteins associated with paclitaxel resistance of epithelial ovarian cancer using iTRAQ-based proteomics

Chemotherapy is an important adjuvant therapy for epithelial ovarian cancer (EOC). The main cause of chemotherapy failure in EOC is paclitaxel resistance. The present study aimed to identify novel biomarkers to predict chemosensitivity to paclitaxel and improve our understanding of the molecular mec...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuanjing, Li, Hongxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004651/
https://www.ncbi.nlm.nih.gov/pubmed/29928353
http://dx.doi.org/10.3892/ol.2018.8600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004651/
https://www.ncbi.nlm.nih.gov/pubmed/29928353
http://dx.doi.org/10.3892/ol.2018.8600

Ejemplares similares